Edwardine Labay

Title: Edwardine Labay: Innovator in Cancer Therapy Predictive Markers

Introduction

Edwardine Labay is a notable inventor based in Des Plaines, Illinois. She has made significant contributions to the field of cancer research, particularly in the development of predictive markers for therapy response. Her work focuses on improving patient outcomes through innovative genetic insights.

Latest Patents

Edwardine Labay holds a patent for "Prognosis and therapy predictive markers and methods of use." This patent discloses a set of genes that are differentially expressed in chemotherapy and radiation-resistant tumors. These genes are instrumental in predicting patient responses to therapy and assessing the risks of local-regional failure, survival, and metastasis in cancer patients. Additionally, the patent outlines methods for characterizing tumors based on gene expression and includes kits designed for use in these methods.

Career Highlights

Labay is affiliated with the University of Chicago, where she continues her research and development efforts. Her work has the potential to transform cancer treatment protocols and enhance the precision of therapeutic interventions.

Collaborations

She has collaborated with esteemed colleagues such as Ralph R. Weichselbaum and Bernard Roizman, contributing to a rich environment of innovation and research excellence.

Conclusion

Edwardine Labay's contributions to cancer research through her innovative patent highlight her role as a leading inventor in the field. Her work not only advances scientific understanding but also aims to improve the lives of cancer patients.